Two Sigma Investments’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,322
Closed -$49.2K 3240
2024
Q4
$49.2K Sell
27,322
-6,090
-18% -$11.4K ﹤0.01% 3048
2024
Q3
$70.8K Sell
33,412
-6,877
-17% -$14.9K ﹤0.01% 2935
2024
Q2
$75.3K Sell
40,289
-9,591
-19% -$25.2K ﹤0.01% 2852
2024
Q1
$132K Sell
49,880
-2,367
-5% -$6.55K ﹤0.01% 2795
2023
Q4
$161K Buy
+52,247
New +$124K ﹤0.01% 2879
2022
Q4
Sell
-13,303
Closed -$30K 2828
2022
Q3
$30K Buy
+13,303
New +$40.3K ﹤0.01% 2358
2022
Q2
Sell
-131,848
Closed -$599K 2567
2022
Q1
$599K Buy
+131,848
New +$726K ﹤0.01% 1931
2021
Q3
Sell
-22,354
Closed -$346K 4284
2021
Q2
$346K Sell
22,354
-23,887
-52% -$402K ﹤0.01% 3392
2021
Q1
$935K Buy
46,241
+15,806
+52% +$391K ﹤0.01% 2386
2020
Q4
$824K Buy
+30,435
New +$683K ﹤0.01% 2150
2020
Q3
Sell
-43,698
Closed -$778K 3137
2020
Q2
$778K Buy
+43,698
New +$665K ﹤0.01% 1696
2019
Q3
Sell
-40,679
Closed -$635K 3490
2019
Q2
$635K Buy
+40,679
New +$726K ﹤0.01% 2312
2019
Q1
Sell
-10,792
Closed -$180K 3071
2018
Q4
$180K Buy
+10,792
New +$250K ﹤0.01% 2735

Other funds holding CLLS

Two Sigma Investments's CLLS Position: Q1 2025 in Review

Two Sigma Investments sold out of Cellectis (CLLS) in Q1 2025, closing a stake of 27,322 shares — an estimated $49.2K sold.

Two Sigma Investments first reported a position in CLLS in Q4 2018 and held it in 13 quarters. The position peaked at $935K in Q1 2021. 27 funds tracked by Wall St. Rank hold CLLS as of Q1 2025.

  • Two Sigma Investments reported no remaining Cellectis position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Investments sold 27,322 Cellectis shares in Q1 2025, an estimated $49.2K.
  • Two Sigma Investments first reported a position in Cellectis in Q4 2018 and held it in 13 quarters.
  • Two Sigma Investments's Cellectis position peaked at $935K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.